KIAA1429 Monoklonaler Antikörper
KIAA1429 Monoklonal Antikörper für WB, IHC, FC (Intra), Indirect ELISA
Wirt / Isotyp
Maus / IgG1
Getestete Reaktivität
human, Maus
Anwendung
WB, IHC, FC (Intra), Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
3F1A4
Kat-Nr. : 68235-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
68235-1-PBS bindet in WB, IHC, FC (Intra), Indirect ELISA KIAA1429 und zeigt Reaktivität mit human, Maus
| Getestete Reaktivität | human, Maus |
| Wirt / Isotyp | Maus / IgG1 |
| Klonalität | Monoklonal |
| Typ | Antikörper |
| Immunogen | KIAA1429 fusion protein Ag22449 |
| Vollständiger Name | KIAA1429 |
| Berechnetes Molekulargewicht | 1812 aa, 202 kDa |
| Beobachtetes Molekulargewicht | 200-210 kDa |
| GenBank-Zugangsnummer | BC113380 |
| Gene symbol | KIAA1429 |
| Gene ID (NCBI) | 25962 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-G-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
VIRMA (KIAA1429) is a key component of m6A methyltransferase (writer) complex that include METTL3, METTL14, WTAP, VIRMA, HAKAI, ZC3H13, and RBM15. VIRMA mediates methylation in the 3'UTR and around the stop codon, thus affecting alternative polyadenylation. VIRMA has been reported to act as an oncogenic factor in breast cancer and liver cancer. KIAA1429 exhibits differential nuclear and cytoplasmic distribution in colorectal cancer samples, and high cytoplasmic expression of KIAA1429 is associated with poor response to chemotherapy. BRAF-mediated phosphorylation of KIAA1429 facilitates its aggregation in the cytoplasm. Furthermore, cytoplasmic KIAA1429 promotes WNT pathway activation by binding and stabilizing FZD7, thereby further enhancing cancer stemness and oxaliplatin resistance (PMID: 40611274).







